Back to Virginia

SB379 • 2026

Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.

An Act to direct the Board of Pharmacy to reschedule psilocybin upon federal scheduling changes.

Healthcare
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Boysko
Last action
2026-04-06
Official status
Acts of Assembly Chapter
Effective date
Not listed

Plain English Breakdown

The official source does not provide details on the exact timeline or process after federal changes are published, leaving some uncertainty.

Psilocybin Rescheduling Act

This act requires the Board of Pharmacy to change how psilocybin is regulated based on federal decisions.

What This Bill Does

  • Requires the Board of Pharmacy to reschedule psilocybin when the FDA approves a formulation for medical use and it is published in the Federal Register.
  • The Board must follow federal scheduling changes and procedures contained in state law.

Who It Names or Affects

  • Board of Pharmacy
  • Health care professionals who might administer psilocybin

Terms To Know

Psilocybin
A chemical found in certain mushrooms that can affect the brain and cause hallucinations.
FDA
The U.S. Food and Drug Administration, a government agency that regulates food, drugs, and medical devices.

Limits and Unknowns

  • Does not specify what happens if the FDA does not approve psilocybin for medical use.
  • It is unclear how quickly the Board of Pharmacy will act after federal changes are published.

Bill History

  1. 2026-04-06 Governor

    Approved by Governor-Chapter 306 (effective 7/1/2026)

  2. 2026-04-06 Governor

    Approved by Governor-Chapter 306 (effective 7/1/2026)

  3. 2026-04-06 Governor

    Acts of Assembly Chapter text (CHAP0306)

  4. 2026-03-10 Senate

    Enrolled Bill communicated to Governor on March 10, 2026

  5. 2026-03-10 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  6. 2026-02-26 House

    Signed by Speaker

  7. 2026-02-26 Senate

    Signed by President

  8. 2026-02-26 Senate

    Enrolled

  9. 2026-02-26 Senate

    Bill text as passed Senate and House (SB379ER)

  10. 2026-02-26 Senate

    Fiscal Impact Statement from Department of Planning and Budget (SB379)

  11. 2026-02-24 House

    Read third time

  12. 2026-02-24 House

    Passed House Block Vote (98-Y 0-N 0-A)

  13. 2026-02-23 House

    Read second time

  14. 2026-02-19 Health and Human Services

    Reported from Health and Human Services (21-Y 0-N)

  15. 2026-02-13 House

    Placed on Calendar

  16. 2026-02-13 Health and Human Services

    Referred to Committee on Health and Human Services

  17. 2026-02-13 House

    Read first time

  18. 2026-02-11 Education and Health

    Fiscal Impact Statement from Department of Planning and Budget (SB379)

  19. 2026-02-10 Senate

    Read third time and passed Senate Block Vote (40-Y 0-N 0-A)

  20. 2026-02-09 Senate

    Read second time

  21. 2026-02-09 Senate

    Engrossed by Senate - committee substitute Block Vote (Voice Vote)

  22. 2026-02-09 Education and Health

    Education and Health Substitute agreed to

  23. 2026-02-09 Senate

    Engrossed by Senate Block Vote (Voice Vote)

  24. 2026-02-06 Education and Health

    Committee substitute printed 26106612D-S1

  25. 2026-02-06 Senate

    Rules suspended

  26. 2026-02-06 Senate

    Passed by for the day

  27. 2026-02-06 Senate

    Constitutional reading dispensed Block Vote (on 1st reading) (39-Y 0-N 0-A)

  28. 2026-02-06 Senate

    Passed by for the day Block Vote (Voice Vote)

  29. 2026-02-05 Education and Health

    Reported from Education and Health with substitute (14-Y 0-N)

  30. 2026-01-30 Health Professions

    Senate subcommittee offered

  31. 2026-01-30 Health Professions

    Senate subcommittee offered

  32. 2026-01-30 Health Professions

    Assigned Education sub: Health Professions

  33. 2026-01-29 Senate

    Fiscal Impact Statement from Department of Planning and Budget (SB379)

  34. 2026-01-13 Senate

    Prefiled and ordered printed; Offered 01-14-2026 26104820D

  35. 2026-01-13 Education and Health

    Referred to Committee on Education and Health

Official Summary Text

Board of Pharmacy; regulation of psilocybin.
Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to HB 1347.

Current Bill Text

Read the full stored bill text
An Act to direct the Board of Pharmacy to reschedule psilocybin upon federal scheduling changes.
Be it enacted by the General Assembly of Virginia:
1.
§ 1. Upon approval by the U.S. Food and Drug Administration (FDA) of a formulation of psilocybin designed to be administered by a health care professional in a health care setting, the Board of Pharmacy shall reschedule such formulation of psilocybin consistent with federal scheduling changes and procedures contained in subsection E of §
54.1-3443
of the Code of Virginia at its next quarterly meeting following the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule designating any formulation of psilocybin that has been approved by the FDA as a controlled substance.